Crossbow Therapeutics Inc. has provided details on the preclinical characterization for the telomerase reverse transcriptase (TERT)-targeting T-cell engager CBX-663.

Emily Norris is the managing editor of Traders Reserve; she has 10+ years of experience in financial publishing and editing and is an expert on business, personal finance, and trading. Dr. JeFreda R.

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Transcription factors are proteins that bind to DNA to regulate gene expression via transcription: the process by which the genetic code generates mRNAs or small RNAs. Transcription factors operate by ...

A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic ...

Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some o ...

H2Bub1 is a master epigenetic regulator that orchestrates the elongation-to-termination transition of sense transcription in S. pombe by directly modulating a Cdk9-PP1 switch mechanism. Loss of H2Bub1 ...

Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's first capsid inhibitor.In ...

Coronavirus disease 2019 COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID ...

Women's IC Champion Maxxine Dupri recently reflected on having a difficult time with hate she received online earlier in her ...

A high-fat diet forces liver cells to adapt for survival rather than function, creating metabolic stress that affects ...